Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
European phase-II trial of low-dose aldesleukin (rhIL-2) in recent-onset type 1 diabetes
2014-002522-12Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2014
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of aldesleukin in diabetes mellitus type 1 (T1D), sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2014; status: completed.
02
Drugs
aldesleukin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2014-002522-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002522-12.